EUCLID HOSPITAL — History
CCN 360082 | 3-year financial timeline | COVID resilience: 65/100
🛡️ Public data only — no PHI permitted on this instance.
$106M
Latest Revenue (FY2022)
+6.9%
Revenue CAGR (3yr)
-14.4%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $93M | $114M | $106M | -6.4% | +6.9% |
| Operating Expenses | $110M | $118M | $122M | +2.9% | +5.1% |
| Operating Margin | -18.2% | -4.0% | -14.4% | -261.0% | +0.0% |
| Net Income | $-17M | $-5M | $-15M | -237.9% | +0.0% |
| Licensed Beds | 110 | 110 | 110 | +0.0% | +0.0% |
| Total Patient Days | 17,822 | 18,985 | 16,008 | -15.7% | -5.2% |
| Medicare Day % | 27% | 23% | 20% | -12.4% | -14.6% |
| Medicaid Day % | 6% | 5% | 6% | +19.5% | +4.0% |
COVID Impact & Recovery
Resilience Score: 65/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +14.3% ($93M → $106M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+6.9%
This Hospital
+7.6%
State Avg
Latest Margin
-14.4%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $113M | -12.5% |
| FY2024 (proj) | $120M | -10.5% |
| FY2025 (proj) | $126M | -8.6% |